December 07, 2004 - Red Herring Selects Kinexus Bioinformatics Corporation For Prestigious Red Herring Top 100 Innovators Award
The Award Recognizes 100 Companies That Embody Innovation

August 10, 2004 - Kinexus Bioinformatics Corporation Announces the Appointment of Two New Directors to its Board
Senior Executives Bring Diverse Expertise to the Board of Kinexus

July 26, 2004 - Kinexus Validates PLK1 as a Cancer Drug Target
Polo-like Kinase-1 Inhibition Blocks B23/nucleophosmin-mediated Centrosome Duplication in Tumour Cells

September 23, 2003 - Kinexus Receives Eligible Business Corporation (EBC) Status
Kinexus Investors can Receive a 30% Refundable Tax Credit

July 23, 2003 - Kinexus Announces Two New Phospho-Site Screening Services
Kinetworks™ Phosphosite Arrays Developed in Collaboration with Biosource International

March 11, 2003 - Kinexus Announces the Release of New Cell Cycle Screen
New Kinetworks™ Screen Tracks 30 Proteins Involved in Cell Growth and Proliferation

December 16, 2002 - Kinexus Study Reveals Unexpected Changes in Protein Kinase Profiles
Kinexus Study Reveals Profound Changes in Protein Kinase Composition Between Rat and Monkey Tissues as Published on the Science Magazine’s Signal Transduction Knowledge Environment

September 20, 2002 - Kinexus Named a 2002 Venture All Star Company
The Pacific Northwest's Venture Event of the Year Honored Kinexus Bioinformatics Corporation as One of the Top Venture-Backed Companies in the Region

July 01, 2002 - Kinexus Introduces New Apoptosis Protein Profiling Service
Kinetworks™ Screening Service Designed to Improve Discovery Based Research

May 06, 2002 - Kinexus Bioinformatics Completes First Stage Equity Financing
Kinexus Raises $0.5 Million from a Syndicate of Investors

April 16, 2002 - Kinexus Appoints Chief Executive Officer
David W. Turner Named CEO and Director

January 30, 2002 - Kinexus Bioinformatics Corporation Announces the Launch of its Fourth Proteomics Analysis Service
Stress and Heat Shock Protein Screen Available to the Public